LIANY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
LIANY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
LianBio's Accounts Payable for the quarter that ended in Sep. 2023 was $6.23 Mil.
LianBio's quarterly Accounts Payable declined from Mar. 2023 ($5.43 Mil) to Jun. 2023 ($1.91 Mil) but then increased from Jun. 2023 ($1.91 Mil) to Sep. 2023 ($6.23 Mil).
LianBio's annual Accounts Payable declined from Dec. 2020 ($4.33 Mil) to Dec. 2021 ($3.23 Mil) and declined from Dec. 2021 ($3.23 Mil) to Dec. 2022 ($1.45 Mil).
The historical data trend for LianBio's Accounts Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LianBio Annual Data | |||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | |||||
Accounts Payable | - | 4.33 | 3.23 | 1.45 |
LianBio Quarterly Data | |||||||||||||||
Dec19 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
Accounts Payable | Get a 7-Day Free Trial | 2.02 | 1.45 | 5.43 | 1.91 | 6.23 |
Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.
Thank you for viewing the detailed overview of LianBio's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.
Perceptive Life Sciences Master Fund Ltd | 10 percent owner | C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003 |
Wei Wei Chen | director | C/O LIANBIO, 103 CARNEGIE CENTER DRIVE, SUITE 309, PRINCETON NJ 08540 |
Debra Yu | officer: See Remarks | C/O PERCEPTIVE ADVISORS, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003 |
C2 Life Sciences Llc | 10 percent owner | 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003 |
Lev Lb Holdings Gp, Llc | 10 percent owner | 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003 |
Perceptive Venture Advisors, Llc | 10 percent owner | 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003 |
Susan Michele Silbermann | director | C/O LIANBIO, 103 CARNEGIE CENTER DRIVE, SUITE 215, PRINCETON NJ 08540 |
Brianne Jahn | officer: Chief Business Officer | C/O LIANBIO, 103 CARNEGIE CENTER DRIVE, SUITE 215, PRINCETON NJ 08540 |
Yizhe Wang | director, officer: Chief Executive Officer | 103 CARNEGIE CENTER DRIVE, SUITE 215, PRINCETON NJ 08540 |
Jiang Qian | officer: China General Manager | C/O LIANBIO, 103 CARNEGIE CENTER DRIVE, SUITE 215, PRINCETON NJ 08540 |
Lev Lb Holdings, Lp | 10 percent owner | 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003 |
Joseph Edelman | 10 percent owner | C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003 |
Perceptive Xontogeny Venture Fund, Lp | 10 percent owner | C/O PERCEPTIVE ADVISORS, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003 |
Yi Larson | officer: Chief Financial Officer | C/O RAYZEBIO, INC., 5505 MOREHOUSE DRIVE, SUITE 300, SAN DIEGO CA 92121 |
Neil Kumar | director | C/O BRIDGEBIO PHARMA, INC., 3160 PORTER DR, STE 250, PALO ALTO CA 94304 |
From GuruFocus
By Marketwired • 07-17-2023
By GuruFocus Research • 02-07-2024
By GuruFocus Research • 02-07-2024
By GuruFocus Research • 02-07-2024
By Marketwired • 08-14-2023
By GuruFocus Research GuruFocus Editor • 07-15-2022
By Marketwired • 08-28-2023
By sperokesalga sperokesalga • 06-01-2023
By Marketwired • 07-26-2023
By Value_Insider Value_Insider • 11-09-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.